Showing 51 to 75 of 131 Results
Page 1 | 2 | 3 | 4 | 5 | 6
Gore Medical Receives National Honor for Operational Excellence
20 June 2013 - W. L. Gore & Associates named as a winner of the eighth annual Pinnacle Award


New Clinical Evidence Supporting Efficacy of GORE® PROPATEN® Vascular Graft
19 January 2011 - Jes Lindholt, MD, PhD presented new study data from a Scandinavian clinical trial designed to compare patency rates of the GORE PROPATEN Vascular Graft with standard ePTFE grafts (GORE-TEX® Stretch Vascular Graft).

GORE® EXCLUDER® Iliac Branch Endoprosthesis Gains FDA Approval
03 March 2016 - Gore designed all-in-one system to preserve iliac artery blood flow in patients with iliac or aortoiliac aneurysms


Gore Announces Broadened FDA Indication for GORE VIABAHN® Endoprosthesis for Iliac Occlusive Disease
17 September 2008 - Only Stent-Graft Approved for Treatment of Both Iliac and Superficial Femoral Arteries


Global Vascular Thought Leaders Document Shift toward Individualizing Patient Care in Surgical Bypass
17 June 2015 - Presentations and Discussions from the Surgical Bypass Summit Available at www.surgicalbypass.com

Gore Receives FDA Approval for Modification of GORE VIABAHN® Endoprosthesis
17 September 2008 - Manufacturing modification of the only stent-graft approved for treatment of both iliac and superficial femoral arteries.

GORE® Septal Occluder Honored as Best In Show and Gold Winner in the 2013 Medical Design Excellence Awards
26 June 2013 - Recognition for Innovation in Expanding Treatment Options for Patients

First Patient Enrolled in Gore Early TIPS for Ascites Study at Indiana University Hospital
25 April 2011 - Clinical Study to Examine Effects of Early Intervention with Transjugular Intrahepatic Portosystemic Shunt (TIPS) Therapy on Transplant-Free Liver Disease Survival Rates

Gore Receives Health Canada Approval for Removable GORE® VIABIL® Biliary Endoprosthesis
17 January 2011 - New treatment option now available for benign and malignant biliary strictures

Gore Again Named One of the 100 Best Companies to Work For®
03 March 2016 - Every year since 1998: That’s how long W. L. Gore & Associates has appeared on the Fortune 100 Best Companies to Work For® list

First Patient Enrolled in Gore TAG Thoracic Branch Endoprosthesis LSA Feasibility Study
27 January 2014 - Multi-Center Study to Assess Feasibility of Gore Device to Treat Historically Challenging Patient Population

Gore receives FDA approval for GORE VIABAHN® Endoprosthesis with Heparin Bioactive Surface
05 September 2007 - Heparin-Bonded Endoprosthesis for Superficial Femoral Artery Interventions


England National Institute for Health Research Stroke Research Network Adopts Gore REDUCE Clinical Study
19 June 2012 - Study Investigates Device Closure of Patent Foramen Ovale (PFO) in Stroke Reduction.

GORE® EXCLUDER® Conformable AAA Endoprosthesis Receives Approval for Clinical Study in the US and Japan
16 June 2015 - Device designed to bring endovascular therapy options to patients previously considered untreatable

Gore Receives CE Mark Approval for Removable GORE® VIABIL® Biliary Endoprosthesis
27 April 2010 - Expanded indication enables stent removal for up to 12 months following implantation for effective treatment of both malignant and benign biliary strictures.

Gore Prevails in Heart Device Patent Infringement Suit
05 August 2013 - W. L. Gore & Associates (Gore) today announced a favorable ruling involving the GORE® HELEX® Septal Occluder.

First Australian Patients Enrolled in Gore Global Registry for Endovascular Aortic Treatment
20 March 2012 - Royal Prince Alfred Hospital First in Australia

Gore Announces European Availability of Next Evolution of GORE® VIABAHN® Endoprosthesis
19 January 2011 - Lower profile delivery system in Europe provides more options for endoluminal bypass

Gore Launches Clinical Quality Improvement (CQI) Project of New Hernia Repair Device
24 March 2016 - New research methodology will procure real world feedback from surgeons and patients to improve outcomes with GORE® SYNECOR Biomaterial

Gore and AAAneurysm Outreach Partner to Increase Early Detection of Abdominal Aortic Aneurysm (AAA)
28 January 2014 - New Campaign Will Employ Awareness, Community Outreach, and Patient Screening to Fight AAA

Gore Receives FDA Approval for Modification of GORE VIABAHN® Endoprosthesis
17 September 2008 - Manufacturing modification of the only stent-graft approved for treatment of both iliac and superficial femoral arteries.

Gore Joins Vascular and Endovascular Leaders in Recognizing the 2014 Pioneers in Performance for North America
19 November 2014 - Leading Practitioners and Researchers from North America Commended for Commitment to Advancing Vascular and Endovascular Therapy

GORE® Hybrid Vascular Graft Honored as Gold Winner in the 2012 Medical Design Excellence Awards
03 July 2012 - W. L. Gore & Associates (Gore) today announced that the GORE® Hybrid Vascular Graft was awarded Gold Winner in the Implant and Tissue-Replacement Products category of the 2012 Medical Design Excellence Awards (MDEA) competition.

Gore Applauds Medicare Announcement to Reclassify Endovascular Abdominal Aneurysm Repairs
03 August 2015 - Decision comes after two-year effort to improve the alignment of payment with cost of treatment for abdominal aortic aneurysms

Gore RELINE MAX Study Patient Enrollment Press Release - English

First Patients Enrolled in the Gore RELINE MAX Clinical Study

(45 KB, 3 pages, .pdf)


Gore Receives Approval from FDA for Unique Patent Foramen Ovale Stroke Study
05 May 2008 - Multinational trial randomizes stroke patients with Patent Foramen Ovale (PFO) to closure with the GORE HELEX Septal Occluder versus medical management

W. L. Gore & Associates Presents New Data and Clinical Updates at Transcatheter Cardiovascular Therapeutics (TCT) Conference 2008
08 October 2008 - Gore continues commitment to clinical research with symposia, ongoing clinical studies and emerging technologies

First Patient Enrolled in Gore® SCAFFOLD Clinical Study for Carotid Stenting
12 September 2013 - Pivotal Multicenter Investigational Study Begins at Medical University of South Carolina (MUSC), Evaluating Safety and Efficacy of Innovative GORE® Carotid Stent

GORE® Hybrid Vascular Graft Commercially Available in the United States
01 June 2011 - W. L. Gore & Associates today is announcing commercial availability in the US of the GORE® Hybrid Vascular Graft.

Gore REDUCE Clinical Study Completes Enrollment
25 February 2015 - Study of Closure of Patent Foramen Ovale (PFO) in Stroke Patients Reaches Major Milestone

Improved GORE® DrySeal Sheath with Hydrophilic Coating Launches in Europe
23 January 2013 - New Product Engineered to Increase Sheath Lubricity, Minimize Coating Particulation for Easier Insertion and Removal in Treating Patients with AAA and TAA

Gore Announces FDA Approval of Next Evolution of GORE® VIABAHN® Endoprosthesis
17 February 2011 - Lower profile delivery system in the US provides more options for endoluminal bypass

Gore Launches Unique Biomaterial for Complex Ventral Hernia Repair
30 March 2016 - Gore to launch its new hybrid device, GORE® SYNECOR Biomaterial, at the 17th Annual Hernia Repair Conference in Washington, D.C.

Gore REVISE Clinical Study Demonstrates Superiority of GORE VIABAHN Endoprosthesis
20 February 2014 - GORE Device Outperforms Standard Treatment Option for Stenoses or Thrombotic Occlusions

Gore Recognizes Physicians as “Pioneers in Performance” for Exceptional Work in the Field of Endovascular Therapy
17 February 2009 - Leading practitioners and researchers from around the world commended for expanding treatment options for at-risk patients

First Patients Enrolled in Gore Thoracoabdominal Aortic Aneurysm Clinical Study
13 November 2014 - Device offers first and only complete “off-the-shelf” endovascular system specifically designed to treat aortic aneurysms involving visceral branch vessels

Gore REDUCE Clinical Study Principal Investigators Respond to Recent RESPECT Clinical Trial and PC Trial Results
15 November 2012 - Gore REDUCE Clinical Study Investigators Implored to Continue Enrollment, Drive 'Diligent Continuation of Study'


Gore Receives CE Mark for New GORE® EXCLUDER® AAA Endoprosthesis Sizing Options
03 July 2012 - Broader Range of Sizes Now Accommodates More Patient Anatomies

Nominees Announced for 2016 Pioneers in Performance Awards for North America; Online Voting Opens at www.PioneersInPerformance.com
18 November 2015 - Awards Program Honors Medical Specialists Advancing Therapy and Improving Patient and Clinical Performance Through Active Collaboration

First Patients Enrolled in the Gore RELINE MAX Clinical Study
16 December 2015 - 108 patient trial to add evidence for treatment of in-stent restenosis using the GORE® VIABAHN® Endoprosthesis

Gore Global Registry for Endovascular Aortic Treatment Reaches 2,500 Enrolled Patients - English

Conformable GORE® TAG® Thoracic Endoprosthesis, GORE® EXCLUDER® AAA Endoprosthesis, GORE® EXCLUDER® Iliac Branch Endoprosthesis, GORE® TAG® Thoracic Endoprosthesis

(47 KB, 2 pages, .pdf)


Rush University Medical Center First to Enroll Patient in the Gore REDUCE Clinical Study for the Indication of Patent Foramen Ovale (PFO) Closure
11 December 2008 - Multi-national trial to demonstrate safety, effectiveness of GORE HELEX Septal Occluder for PFO closure in patients with a history of cryptogenic stroke

Vascular Surgeons Present Positive Study Results for the GORE PROPATEN® Vascular Graft and Updates to the GORE VIABAHN® Endoprosthesis
17 September 2009 - Physicians report new information at the Society for Vascular Surgery's annual meeting

Gore Receives First FDA Approval for Endovascular Repair of Aortic Dissection
11 September 2013 - Conformable GORE® TAG® Thoracic Endoprosthesis First to Receive Indication for Aneurysm, Trauma and Dissection

Gore Receives FDA Approval for Conformable GORE® TAG® Thoracic Endoprosthesis
16 November 2011 - Durable ePTFE Endoprosthesis Designed for Endovascular Repair of the Descending Thoracic Aorta Provides Conformability without Compromise

Gore Global Registry for Endovascular Aortic Treatment Reaches 2,500 Enrolled Patients
28 February 2015 - Milestone Achievement in Monitoring Patient Outcomes and Device Performance

W. L. Gore & Associates Named a Top U.S. Workplace
16 January 2013 - Company has appeared in every listing of the “100 Best Companies to Work For”

Gore Receives CE Mark for GORE® PROPATEN® Vascular Graft for Hemodialysis Access
22 February 2011 - Unique Vascular Graft Transcends Mechanical Solutions for Dialysis Access

GORE® EXCLUDER® Device Reaches Significant Milestone
17 February 2016 - Proven device for endovascular aneurysm repair (EVAR) reaches 250,000 patients worldwide

GORE® EXCLUDER® Iliac Branch Endoprosthesis Gains Health Canada Approval
21 April 2016 - Global reach expanded for the solution that physicians trust and patients count on

Gore Presents Astronaut and Scientist Mae C. Jemison, MD, as Keynote Speaker at Women in Vascular Leadership Luncheon
18 March 2014 - The pioneering Dr. Jemison, who flew aboard the Space Shuttle Endeavour, will address vascular surgeons at the 2014 SCVS symposium in Carlsbad, Calif.

Gore REVISE Study Receives Approval From FDA
07 April 2008 - The Gore REVISE Study is a randomized, multi-center clinical trial intended to establish efficacy and safety of the GORE VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface to revise arterio-venous grafts at the venous anastomosis in hemodialysis patients.

Gore Receives Health Canada Approval for GORE® VIABAHN® Endoprosthesis Innovations, Treating Peripheral Vascular Disease
04 February 2015 - Longer and Lower Profile Options Now Available in Canada to Treat More Patient Anatomies

Improved GORE® DrySeal Sheath with Hydrophilic Coating Allows for Smooth and Minimally Invasive Endovascular Repair
18 December 2012 - Engineered to Increase Sheath Lubricity and Minimize Coating Particulation for Easier Insertion and Removal in Treatment of Patients with AAA and TAA

Gore Reacts to RESPECT Trial Results
26 October 2012 - Data Calls for Further Research on Transcatheter Patent Foramen Ovale (PFO) Closure

Gore Receives CE Mark for GORE® Hybrid Vascular Graft
16 August 2012 - More than 2500 Successful Implants for Dialysis Access and Other Vascular Procedures

Gore Achieves 40 Million Implants Sold Worldwide as it Celebrates 40 Years of Performance
17 November 2015 - Milestones a testament on its 40-year legacy of designing devices to improve patient outcomes

Now Published in the Annals of Surgery: Long-Term Favorable Results Demonstrate GORE® BIO-A® Tissue Reinforcement Efficacy in Complex Ventral Hernia Repairs
04 January 2016 - Final study results demonstrate for the first time efficacy of long-lasting absorbable biosynthetic mesh in challenging hernia repairs; has potential to end biologics era in hernia repair.

Product Launch Press Release - English

GORE® SYNECOR Biomaterial

(31 KB, 2 pages, .pdf)


Endovascular Repair of Descending Thoracic Aortic Aneurysm
25 October 2007 - On November 6, 2007, at 3 pm (EST) surgeons and radiologists from the University of Michigan Health System will perform a descending thoracic aortic aneurysm repair with the GORE TAG® Thoracic Endoprosthesis.

Gore Receives FDA Approval for Next Generation of Large Diameter GORE VIABAHN® Endoprosthesis with Heparin Bioactive Surface
21 July 2009 - Improved design now available with lower profile delivery system for use in iliac arteries.

Gore Receives FDA Approval for 25 cm GORE® VIABAHN® Endoprosthesis
06 November 2013 - Longest stent-graft introduced in the United States

Nominees Announced for 2011-2012 Pioneers in Performance Awards for the United States; Online Voting Opens at www.PioneersInPerformance.com
16 November 2011 - Awards Program Sponsored by W. L. Gore & Associates Honors Medical Specialists Advancing Therapy and Improving Patient and Clinical Performance Through Active Collaboration

First Patient Enrolled in GORE® TAG® Thoracic Branch Endoprosthesis Early Feasibility Study
28 April 2015 - First Early Feasibility Study of a Gore Device Will Assess Treatment of Aortic Arch Aneurysms

Gore Launches Lower Profile GORE® EXCLUDER® AAA Endoprosthesis Contralateral Leg Components in US and Europe
11 March 2013 - Addition to Series of Reduced Profile GORE® EXCLUDER® Devices Launching This Year


First Implant Completed in Thoracoabdominal Aortic Aneurysm Clinical Study
02 February 2016 - New investigative Gore device is designed to treat aortic aneurysms involving visceral branch vessels

First Successful Implant of GORE® SYNECOR Biomaterial in a Ventral Hernia Patient
25 April 2016 - Unique biomaterial for hernia repair implanted for the first time in Gore’s Clinical Quality Improvement project


Gore REVISE Study Receives Conditional Approval From FDA
12 July 2007 - Conditional approval to proceed with the Gore REVISE (VasculaR AccEss ReVision with GORE VIABAHN® EndoproSthesis vs PercutanEous Transluminal Angioplasty) Study was announced today by W. L. Gore & Associates.

Gore Completes Primary Enrollment for the Gore EXCLUDER® Iliac Branch Clinical Study
17 February 2015 - 62 patients enrolled in US investigational device exemption clinical study to assess first complete, low-profile system for managing common iliac artery aneurysms or aorto-iliac aneurysms

Gore Receives FDA Approval for New GORE® EXCLUDER® AAA Endoprosthesis Components
14 January 2013 - Expanded Treatment Options for Abdominal Aortic Aneurysms Provide More Patients with Access to Minimally Invasive Endovascular Repair

New 10 cm GORE® Hybrid Vascular Graft Delivers Unprecedented Versatility
14 November 2012 - Increased Length of Nitinol Reinforced Section Allows for Access to Deeper Vessels, Extends Landing-Zone Positioning Options

First Patient Enrolled in GORE® Septal Occluder Clinical Study for Atrial Septal Defect
19 October 2012 - Pivotal Multicenter Trial Begins at Duke University, Evaluating Safety and Efficacy of Innovative ASD Closure Device

GORE® EXCLUDER® Iliac Branch Endoprosthesis Exceeds 1,000 Implants Worldwide
17 November 2015 - Innovative system for managing common iliac artery aneurysms or aortoiliac aneurysms impacting lives around the world

Unique Biomaterial for Hernia Repair Receives FDA 510K Clearance
19 January 2016 - GORE® SYNECOR Biomaterial combines strength of PTFE with the tissue-building scaffold of GORE® BIO-A® Web to create an improved device for hernia repair

Showing 51 to 75 of 131 Results
Page 1 | 2 | 3 | 4 | 5 | 6